Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 573 of 6351
-
New hope for Hard-to-Treat lymphoma: drug cocktail shows promise
Disease control Not yet recruitingThe goal of this phase 2 trial is to test the safety and efficacy of G-Pola-GemOx as induction therapy in patients with Refractory/Relapsed Aggressive B-Cell Lymphoma.
Phase 2 • Sponsor: Navy General Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Experimental drug combo aims to fight deadly brainstem glioma
Disease control Not yet recruitingPatients ≥ 3 years of age with newly-diagnosed, diffuse, intrinsic pontine glioma will be enrolled in this study. However, the primary objectives of this study are to 1) compare overall survival, the time from randomization to death from any cause, for study subjects 3-21 years o…
Phase 3 • Sponsor: Burzynski Research Institute • Aim: Disease control
Last updated Jun 26, 2026 18:42 UTC
-
New drug aims to save kidneys: 3,000-Patient trial launches
Disease control Not yet recruitingChronic kidney disease CKD is estimated to affect nearly over 800 million people globally today (with roughly 125,000 people ending up annually on dialysis in the United States alone. CKD is a contributor to illness and is associated with a diminished quality of life and reduced …
Phase 2/3 • Sponsor: Ebima Clifford Okundaye • Aim: Disease control
Last updated Jun 26, 2026 14:50 UTC
-
Poop pills could save lives of blood cancer patients
Disease control By invitation onlyIn Hungary - in comparison to other member states of the European Union - about 75000 new cases of cancer are diagnosed annually, from which approximately 4500-5000 patients suffer from so-called malignant hematological diseases. This disease group includes various leukemias (blo…
Sponsor: Del-Pest Central Hospital - National Institute of Hematology and Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New hope for rare blood cancer: drug cocktail targets resistant lymphoma
Disease control Not yet recruitingIn decades, the outcome of patients with peripherial T-cell lymphomas is dismal, especially in relapsed or refractory population. After failure to the frontline treatment, patients have limited treatment options and elderly population usually have no chance to undergo transplanta…
Phase 1/2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Brain zaps and VR worlds: a new hope for early Alzheimer's?
Disease control Not yet recruitingAs populations age, Alzheimer's disease (AD) is increasing while disease-modifying drugs remain elusive, making early diagnosis and intervention essential. Building on advances in neuromodulation and virtual reality (VR), we target amnestic mild cognitive impairment (aMCI)-the pr…
Sponsor: Yuan Shen • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New hope for kids with tough blood cancers: drug cocktail trial launches
Disease control Recruiting nowHEM-iSMART is a master protocol which investigates multiple investigational medicinal products in children, adolescents and young adults (AYA) with relapsed/refractory (R/R) ALL and LBL. Sub-protocol C is a phase I/II trial evaluating the safety and efficacy of ruxolitinib and ve…
Phase 1/2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC
-
Could a mushroom extract boost lung cancer treatment?
Disease control Not yet recruitingThis prospective, single-center, randomized controlled clinical trial aims to evaluate the efficacy and safety of microwave ablation (MWA) combined with Huaier granules in patients with inoperable stage IA non-small cell lung cancer (NSCLC). A total of 180 eligible patients will …
Phase 3 • Sponsor: Xin Ye • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New combo therapy targets stomach cancer lymph nodes
Disease control Recruiting nowThis is a randomized, controlled, multicenter phase II clinical trial evaluating the efficacy and safety of conversion therapy combined with radical gastrectomy and adjuvant radiotherapy targeting para-aortic (station 16) lymph nodes in patients with gastric adenocarcinoma and is…
Phase 2 • Sponsor: Jinbo Yue • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New immunotherapy combo targets rare cancers left behind by progress
Disease control OngoingImmune checkpoint inhibitors (ICI) have revolutionized the management of advanced cancers. However, most rare cancers have been excluded from this progress due to the lack of clinical trials involving these diseases. After the standard first-line treatment, there are no other val…
Phase 2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Umbilical cord stem cells injected into legs to fight diabetic nerve pain
Disease control Recruiting nowThis clinical trial aims to evaluate the efficacy and safety of human umbilical cord mesenchymal stem cell (hUC-MSC) injection in the treatment of adults with moderate to severe diabetic peripheral neuropathy. Researchers will compare hUC-MSCs injection combined with conventiona…
Phase 2 • Sponsor: Min Long • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug MDX2004 targets advanced tumors in early trial
Disease control Recruiting nowThis study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2004 in patients with advanced tumors.
Phase 1/2 • Sponsor: ModeX Therapeutics, An OPKO Health Company • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New combo therapy shows promise for tough breast cancer
Disease control Recruiting nowThis document outlines an investigator-initiated Phase Ib/II clinical trial in Japan, focusing on the combination therapy of ribociclib and anastrozole for patients with hormone receptor-positive (HR-positive), HER2-negative metastatic or recurrent breast cancer. The trial aims t…
Phase 1/2 • Sponsor: Nagoya City University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Coffee for preemies? study tests caffeine to shield tiny kidneys
Prevention CompletedRecent observational data point towards a reduced incidence of acute kidney injury (AKI) with early caffeine use, but high-quality randomized controlled trials comparing early caffeine initiation to supportive therapy alone are lacking. This study aims to fill this critical gap b…
Sponsor: Muhammad Aamir Latif • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
New drug aims to halt rare heart disease progression
Disease control Recruiting nowThe purpose of this study is to confirm that the treatment with acoramidis prevents the deterioration of the ATTR-CM disease progression index and that these indexes are surrogate markers of disease progression.
Phase 4 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can early rhythm control stop hidden heart rhythms from becoming dangerous?
Disease control Recruiting nowAtrial high-rate episodes (AHREs) detected by cardiac implantable electronic devices (CIEDs) are associated with an increased risk of progression to clinical atrial fibrillation (AF), stroke, heart failure, and mortality. However, optimal management strategies for patients with A…
Phase 4 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain zaps plus therapy: a new hope for children with cerebral palsy?
Disease control CompletedTranscranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that may help improve hand function in children with cerebral palsy. This study investigates whether tDCS combined with functional task training is more effective than functional task tra…
Sponsor: October 6 University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Harp melodies may tame Dementia's sundowning storm
Symptom relief CompletedThe ARPE study looked at whether weekly harp therapy sessions could reduce behavioral problems in older adults living in memory care units of a nursing home (EHPAD). These residents had moderate-to-severe neurodegenerative diseases (such as Alzheimer's disease or related conditio…
Sponsor: LNA SANTE • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can tape or a pressure vest ease Post-Radiation breast swelling?
Symptom relief Recruiting nowBreast cancer patients often develop breast lymphedema after breast-conserving surgery and radiotherapy, causing swelling, pain, and heaviness that affect quality of life. This study compares two physical therapy approaches-Kinesio Taping and compression therapy-for relieving bre…
Sponsor: Tangshan People's Hospital • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Can LGBTQ+-Affirmative therapy protocols reduce Self-Harm risk in youth?
Knowledge-focused CompletedAims: 1. To co-produce new intervention parts that meet the needs of LGBTQ+ people at risk of self-harm or suicidal thoughts, with LGBTQ+ people and DBT therapists. These intervention parts will be integrated into a Dialectical Behaviour Therapy (DBT) intervention, that is provi…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC